- Home
- ACHL vs WLGS Comparison
ACHL vs WLGS Comparison
Compare ACHL & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHL
- WLGS
- Stock Information
- Founded
- ACHL 2016
- WLGS 1981
- Country
- ACHL United Kingdom
- WLGS Hong Kong
- Employees
- ACHL N/A
- WLGS N/A
- Industry
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- WLGS Engineering & Construction
- Sector
- ACHL Health Care
- WLGS Consumer Discretionary
- Exchange
- ACHL Nasdaq
- WLGS Nasdaq
- Market Cap
- ACHL 43.6M
- WLGS 41.7M
- IPO Year
- ACHL 2021
- WLGS 2023
- Fundamental
- Price
- ACHL $0.95
- WLGS $2.21
- Analyst Decision
- ACHL Buy
- WLGS
- Analyst Count
- ACHL 2
- WLGS 0
- Target Price
- ACHL $4.00
- WLGS N/A
- AVG Volume (30 Days)
- ACHL 107.8K
- WLGS 129.1K
- Earning Date
- ACHL 11-14-2024
- WLGS 12-31-2024
- Dividend Yield
- ACHL N/A
- WLGS N/A
- EPS Growth
- ACHL N/A
- WLGS N/A
- EPS
- ACHL N/A
- WLGS N/A
- Revenue
- ACHL N/A
- WLGS $6,825,879.00
- Revenue This Year
- ACHL N/A
- WLGS N/A
- Revenue Next Year
- ACHL N/A
- WLGS N/A
- P/E Ratio
- ACHL N/A
- WLGS N/A
- Revenue Growth
- ACHL N/A
- WLGS 63.69
- 52 Week Low
- ACHL $0.63
- WLGS $0.44
- 52 Week High
- ACHL $1.76
- WLGS $5.57
- Technical
- Relative Strength Index (RSI)
- ACHL 29.24
- WLGS 38.98
- Support Level
- ACHL $0.97
- WLGS $2.31
- Resistance Level
- ACHL $1.01
- WLGS $3.19
- Average True Range (ATR)
- ACHL 0.03
- WLGS 0.65
- MACD
- ACHL -0.01
- WLGS -0.23
- Stochastic Oscillator
- ACHL 0.87
- WLGS 2.96
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.